ATE345387T1 - Verbindungen und verfahren für therapie und diagnose von lungenkrebs - Google Patents

Verbindungen und verfahren für therapie und diagnose von lungenkrebs

Info

Publication number
ATE345387T1
ATE345387T1 AT99912607T AT99912607T ATE345387T1 AT E345387 T1 ATE345387 T1 AT E345387T1 AT 99912607 T AT99912607 T AT 99912607T AT 99912607 T AT99912607 T AT 99912607T AT E345387 T1 ATE345387 T1 AT E345387T1
Authority
AT
Austria
Prior art keywords
lung cancer
compounds
diagnosis
methods
therapy
Prior art date
Application number
AT99912607T
Other languages
English (en)
Inventor
Steven G Reed
Tongtong Wang
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/040,984 external-priority patent/US6210883B1/en
Priority claimed from US09/123,912 external-priority patent/US6312695B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Application granted granted Critical
Publication of ATE345387T1 publication Critical patent/ATE345387T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99912607T 1998-03-18 1999-03-17 Verbindungen und verfahren für therapie und diagnose von lungenkrebs ATE345387T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US4080298A 1998-03-18 1998-03-18
US09/040,984 US6210883B1 (en) 1998-03-18 1998-03-18 Compounds and methods for diagnosis of lung cancer
US12393398A 1998-07-27 1998-07-27
US09/123,912 US6312695B1 (en) 1998-03-18 1998-07-27 Compounds and methods for therapy of lung cancer

Publications (1)

Publication Number Publication Date
ATE345387T1 true ATE345387T1 (de) 2006-12-15

Family

ID=27488687

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99912607T ATE345387T1 (de) 1998-03-18 1999-03-17 Verbindungen und verfahren für therapie und diagnose von lungenkrebs

Country Status (13)

Country Link
EP (1) EP1064372B1 (de)
JP (1) JP2002533056A (de)
CN (1) CN1299414A (de)
AT (1) ATE345387T1 (de)
AU (1) AU3094999A (de)
BR (1) BR9908823A (de)
CA (1) CA2323093A1 (de)
DE (1) DE69933998T2 (de)
ES (1) ES2277432T3 (de)
IL (1) IL138330A0 (de)
NO (1) NO20004631L (de)
NZ (1) NZ506699A (de)
WO (1) WO1999047674A2 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
US6458349B1 (en) 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
US7338937B2 (en) * 1997-11-17 2008-03-04 Cornell Research Foundation, Inc. Calcium-activated chloride channel proteins and their use in anti-metastatic therapy
WO1999040183A1 (en) 1998-02-06 1999-08-12 Human Genome Sciences, Inc. Human serine protease and serpin polypeptides
US6737514B1 (en) 1998-12-22 2004-05-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US7049063B2 (en) 1998-03-18 2006-05-23 Corixa Corporation Methods for diagnosis of lung cancer
US6531315B1 (en) 1998-03-18 2003-03-11 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6960570B2 (en) 1998-03-18 2005-11-01 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6660838B1 (en) 1998-03-18 2003-12-09 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6312695B1 (en) 1998-03-18 2001-11-06 Corixa Corporation Compounds and methods for therapy of lung cancer
US7258860B2 (en) 1998-03-18 2007-08-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20040235072A1 (en) * 1998-03-18 2004-11-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6821518B1 (en) 1998-03-18 2004-11-23 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6482597B1 (en) 1999-12-17 2002-11-19 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6706262B1 (en) 1998-03-18 2004-03-16 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US7579160B2 (en) 1998-03-18 2009-08-25 Corixa Corporation Methods for the detection of cervical cancer
US6696247B2 (en) 1998-03-18 2004-02-24 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6518256B1 (en) 1998-03-18 2003-02-11 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6426072B1 (en) 2000-08-02 2002-07-30 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
EP1847607B1 (de) 1998-03-27 2011-06-08 Otsuka Pharmaceutical Co., Ltd. Antikörper gegen das p51 Protein
DE19822985C1 (de) * 1998-05-25 2000-01-13 Fraunhofer Ges Forschung Tumorsuppressorgene der p53-Familie
US6528054B1 (en) * 1998-12-28 2003-03-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6335170B1 (en) 1999-02-22 2002-01-01 Torben F. Orntoft Gene expression in bladder tumors
YU72901A (sh) * 1999-04-02 2004-07-15 Corixa Corporation Preparati za primenu u terapiji i dijagnozi raka pluća
DE19924199A1 (de) * 1999-05-27 2000-11-30 Boehringer Ingelheim Int Tumorassoziiertes Antigen
WO2001016324A2 (en) * 1999-08-31 2001-03-08 Board Of Regents, The University Of Texas System Methods and compositions of a novel serine protease inhibitor
US6855806B1 (en) 1999-10-15 2005-02-15 Curagen Corporation Thymosin beta 10-like proteins and nucleic acids encoding same
US6992170B2 (en) 1999-10-15 2006-01-31 Curagen Corporation Polypeptides and polynucleotides homologous to thymosin, ephrin a receptors, and fibromodulin
EP1222272A2 (de) * 1999-10-15 2002-07-17 Curagen Corporation Polypeptide und dafür kodierende polynukleotide
KR20020064901A (ko) * 1999-11-24 2002-08-10 다케다 야쿠힌 고교 가부시키가이샤 질환관련 유전자의 용도
CA2410624A1 (en) * 2000-05-26 2001-12-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
AU2001266790A1 (en) * 2000-06-09 2001-12-24 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
EP1356093A2 (de) * 2000-06-21 2003-10-29 Hitachi Chemical Co., Ltd. Genmarker für lungenkrebs
JP2004513615A (ja) * 2000-06-28 2004-05-13 コリクサ　コーポレイション 肺癌の治療および診断のための組成物および方法
JP2004524003A (ja) * 2000-06-29 2004-08-12 コリクサ コーポレイション 肺癌の治療および診断のための組成物および方法
US7141365B2 (en) 2001-05-18 2006-11-28 Syntex (U.S.A.) Llc Methods for diagnosing a mucin production associated disease condition
US7358349B2 (en) 2001-08-24 2008-04-15 Hisamitsu Pharmaceutical Co., Inc. Nucleic acids having expression differentials between hepatoblastoma and normal liver
WO2003092597A2 (en) 2002-05-01 2003-11-13 Human Genome Sciences, Inc. Antibodies that specifically bind to chemokine beta-4
SG176801A1 (en) * 2009-06-11 2012-01-30 Minerva Biotechnologies Corp Methods for culturing stem and progenitor cells
SG10201509499RA (en) 2010-11-19 2015-12-30 Eisai R&D Man Co Ltd Neutralizing anti-ccl20 antibodies
CN117417938A (zh) * 2022-01-31 2024-01-19 奥明(杭州)生物医药有限公司 一种环状rna分子及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor

Also Published As

Publication number Publication date
WO1999047674A3 (en) 2000-01-20
CA2323093A1 (en) 1999-09-23
EP1064372B1 (de) 2006-11-15
BR9908823A (pt) 2000-11-21
DE69933998D1 (de) 2006-12-28
NZ506699A (en) 2003-12-19
NO20004631L (no) 2000-11-15
NO20004631D0 (no) 2000-09-15
IL138330A0 (en) 2001-10-31
JP2002533056A (ja) 2002-10-08
AU3094999A (en) 1999-10-11
ES2277432T3 (es) 2007-07-01
WO1999047674A2 (en) 1999-09-23
CN1299414A (zh) 2001-06-13
EP1064372A2 (de) 2001-01-03
DE69933998T2 (de) 2007-10-04

Similar Documents

Publication Publication Date Title
ATE345387T1 (de) Verbindungen und verfahren für therapie und diagnose von lungenkrebs
DE60039353D1 (de) Verbindungen und verfahren für therapie und diagnose von lungenkrebs
WO1999033869A3 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
WO1999038973A3 (en) Compounds for therapy and diagnosis of lung cancer and methods for their use
TW581808B (en) Compounds for immunotherapy of prostate cancer and methods for their use
HUP0002095A2 (hu) Vegyületek prosztatarák immunterápiás kezelésére és alkalmazásuk
NZ516381A (en) Lung tumor proteins in the therapy and diagnosis of lung cancer
HUP0203035A2 (hu) Prosztatarák terápiájára és diagnózisára alkalmas vegyületek és eljárások
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
ZA963907B (en) Insolated nucleic acid molecules peptides which form complexes with mhc molecule hla-a2 and uses thereof
IL153996A0 (en) Polypeptides containing at least a portion of an ovarian carcinoma protein, polynucleotides encoding the same and pharmaceutical compositions containing the same
AR006250A1 (es) Compuestos y metodos para la inmunoterapia e inmunodiagnostico del cancer prostatico
NZ330887A (en) Monoclonals and polyclonals antibodies for the diagnosis of breast cancer
BR9808509A (pt) Composições e métodos para o tratamento e diagnóstico do câncer de mama
WO2000061756A3 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
ATE514780T1 (de) Zusammensetzungen für die therapie und diagnose von brustkrebs und verwendung davon
WO1999037775A3 (en) Compositions and methods for detecting and treating breast cancer
DE60139150D1 (de) Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs
EP1792988A3 (de) Verbindungen und Verfahren für Therapie und Diagnose von Lungenkrebs
WO1999054466A3 (en) Colon cancer-associated antigens and their diagnostic and therapeutic uses
CO5050254A1 (es) Compuestos para el tratamiento y diagnostico del cancer de pulmon
CO5241295A1 (es) Compuestos para inmunoterapia y para el diagnostico del can- cer de mama y metodos para su utilizacion
TW372973B (en) Isolated, truncated nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties